BACKGROUND: Flow diverters are increasingly used for the treatment of intracranial aneurysms. Understanding cavernous internal carotid artery (cICA) tortuosity may help to predict procedural complexities of deploying flow diverters. METHODS: Pipeline embolization device (PED) neurointerventions for ICA aneurysms proximal to the ICA termination were reviewed. Cavernous ICA tortuosity was measured as a ratio D/AP, where D=height difference of the anterior and posterior genus, AP=sum of the angles of the anterior (A) and posterior (P) genus. Four types of cICA tortuosity were proposed. An analysis of variance regression and Fisher's exact test were performed to analyze differences among the types. RESULTS: Cavernous ICA tortuosity was categorized into minimal (type I, n=28), moderate (type II-III, n=29), and severe (type IV, n=26). The groups were comparable for patient age (mean ± SEM years, type I: 55.6±10.4, II-III: 56.4±14.4, IV: 55±12.8) and aneurysm size (mean±SEM mm, type I: 6.25±3.5, II-III: 7.6±4.9, IV: 9.11±4.9). Analysis of variance demonstrated significant differences in procedural fluoroscopy time (mean ± SEM min, type I: 29.8±8.4, II-III: 44.9±34.1, IV: 52.6±17.2, p<0.005) and mean ± SEM D/AP (type I: 0.008±0.0008, II-III: 0.141±0.07, IV: 0.482±0.365, p<0.0001). Procedural complexity was also statistically significant (p<0.005) with 4%, 28%, and 35% of cases in types I, II-III, and IV, respectively, requiring intraprocedural PED removal or balloon post-processing of the implanted PED. CONCLUSIONS: We propose a classification system for cICA tortuosity based on measurements of the anterior and posterior genu geometry. This classification correlates strongly with markers of PED procedural complexity and may be helpful in pre-procedure prognostication. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Flow diverters are increasingly used for the treatment of intracranial aneurysms. Understanding cavernous internal carotid artery (cICA) tortuosity may help to predict procedural complexities of deploying flow diverters. METHODS: Pipeline embolization device (PED) neurointerventions for ICA aneurysms proximal to the ICA termination were reviewed. Cavernous ICA tortuosity was measured as a ratio D/AP, where D=height difference of the anterior and posterior genus, AP=sum of the angles of the anterior (A) and posterior (P) genus. Four types of cICA tortuosity were proposed. An analysis of variance regression and Fisher's exact test were performed to analyze differences among the types. RESULTS: Cavernous ICA tortuosity was categorized into minimal (type I, n=28), moderate (type II-III, n=29), and severe (type IV, n=26). The groups were comparable for patient age (mean ± SEM years, type I: 55.6±10.4, II-III: 56.4±14.4, IV: 55±12.8) and aneurysm size (mean±SEM mm, type I: 6.25±3.5, II-III: 7.6±4.9, IV: 9.11±4.9). Analysis of variance demonstrated significant differences in procedural fluoroscopy time (mean ± SEM min, type I: 29.8±8.4, II-III: 44.9±34.1, IV: 52.6±17.2, p<0.005) and mean ± SEM D/AP (type I: 0.008±0.0008, II-III: 0.141±0.07, IV: 0.482±0.365, p<0.0001). Procedural complexity was also statistically significant (p<0.005) with 4%, 28%, and 35% of cases in types I, II-III, and IV, respectively, requiring intraprocedural PED removal or balloon post-processing of the implanted PED. CONCLUSIONS: We propose a classification system for cICA tortuosity based on measurements of the anterior and posterior genu geometry. This classification correlates strongly with markers of PED procedural complexity and may be helpful in pre-procedure prognostication. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Geoffrey P Colby; Li-Mei Lin; Risheng Xu; Narlin Beaty; Matthew T Bender; Bowen Jiang; Judy Huang; Rafael J Tamargo; Alexander L Coon Journal: Interv Neurol Date: 2017-02-03
Authors: Edward A M Duckworth; Christopher Nickele; Daniel Hoit; Andrey Belayev; Christopher J Moran; Adam S Arthur Journal: BMJ Case Rep Date: 2015-01-30
Authors: Jeremy N Ciporen; Brandon Lucke-Wold; Gustavo Mendez; William E Cameron; Shirley McCartney Journal: World Neurosurg Date: 2016-11-10 Impact factor: 2.104
Authors: J Diego Lozano; Francesco Massari; Mary C Howk; Katyucia de Macedo Rodrigues; Christopher Brooks; Mary Perras; David E Rex; Ajay K Wakhloo; Anna Luisa Kühn; Ajit S Puri Journal: Cureus Date: 2016-05-21
Authors: Fawaz Al-Mufti; Eric R Cohen; Krishna Amuluru; Vikas Patel; Mohammad El-Ghanem; Rolla Nuoman; Neil Majmundar; Neha S Dangayach; Philip M Meyers Journal: Interv Neurol Date: 2018-10-16
Authors: Li-Mei Lin; Rajiv R Iyer; Matthew T Bender; Thomas Monarch; Geoffrey P Colby; Judy Huang; Rafael J Tamargo; Alexander L Coon Journal: Interv Neurol Date: 2017-03-04
Authors: Li-Mei Lin; Bowen Jiang; Matthew T Bender; Erick M Westbroek; Jessica K Campos; Rafael J Tamargo; Judy Huang; Alexander L Coon; Geoffrey P Colby Journal: Interv Neurol Date: 2018-02-06
Authors: Li-Mei Lin; Bowen Jiang; Jessica K Campos; Narlin B Beaty; Matthew T Bender; Rafael J Tamargo; Judy Huang; Geoffrey P Colby; Alexander L Coon Journal: Interv Neurol Date: 2018-02-27